Detlef Albrecht's Net Worth
$148 Thousand
Who is Detlef Albrecht?
Detlef Albrecht does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Satsuma Pharmaceuticals, Inc., and INTRABIOTICS PHARMACEUTICALS INC /DE.
SEC CIK
Detlef Albrecht's CIK is 0001286642
Past Insider Trading and Trends
2020 was Detlef Albrecht's most active year for acquiring shares with 16 total transactions. Detlef Albrecht's most active month to acquire stocks was the month of March. 2020 was Detlef Albrecht's most active year for disposing of shares, totalling 22 transactions. Detlef Albrecht's most active month to dispose stocks was the month of March. 2020 saw Detlef Albrecht paying a total of $36,480.00 for 149,000 shares, this is the most they've acquired in one year. In 2020 Detlef Albrecht cashed out on 15,000 shares for a total of $184,575.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Satsuma Pharmaceuticals, Inc. No price found
Chief Medical OfficerDetlef Albrecht owns 20,212 units of Common Stock, $0.0001 par value and 20,212 units of Common Stock. In the year 2019 Detlef Albrecht acquired a total of 8,000 shares in Satsuma Pharmaceuticals, Inc. at a cost of $36,480.00, Detlef also disposed a total of 8,000 shares of Satsuma Pharmaceuticals, Inc. equalling to $184,575.97.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
$13.39 | -$17,650.00 | 20.21K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$13.74 | -$18,345.62 | 20.21K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$15.62 | -$22,123.05 | 20.21K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$14.91 | -$20,696.90 | 20.21K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$12.28 | -$15,440.00 | 20.21K |
Scheduled
|
May 5
| ||
Form 4/A
|
—
|
0
|
$12.28 | -$12,352.00 | 20.21K |
Scheduled
|
Apr 14
| ||
Form 4/A
|
—
|
0
|
$12.41 | -$3,137.00 | 20.21K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$12.28 | -$12,352.00 | 20.01K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$12.41 | -$3,137.00 | 40.42K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$15.99 | -$22,862.40 | 20.21K |
Scheduled
|
Mar 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTRABIOTICS PHARMACEUTICALS INC /DE No price found
SVP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||